AAA

Affinity Asset Advisors Portfolio holdings

AUM $1.71B
1-Year Est. Return 374.45%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+374.45%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.71B
AUM Growth
+$313M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
118
New
Increased
Reduced
Closed

Top Buys

1
+$28.3M
2
+$26.6M
3
+$20.4M
4
XENE icon
Xenon Pharmaceuticals
XENE
+$19.6M
5
ERAS icon
Erasca
ERAS
+$17.1M

Top Sells

1
+$58.6M
2
+$16.9M
3
+$14.8M
4
ACLX
Arcellx
ACLX
+$14.2M
5
BBIO icon
BridgeBio Pharma
BBIO
+$12.3M

Sector Composition

1 Healthcare 97.1%
2 Financials 0.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELVN icon
26
Enliven Therapeutics
ELVN
$2.19B
$23M 1.35%
+586,904
ASND icon
27
Ascendis Pharma A/S
ASND
$13.4B
$21.7M 1.27%
95,000
+65,000
MLYS icon
28
Mineralys Therapeutics
MLYS
$2.07B
$20.3M 1.19%
750,000
+20,000
AVTX icon
29
Avalo Therapeutics
AVTX
$722M
$20M 1.17%
1,340,840
+289,786
PTGX icon
30
Protagonist Therapeutics
PTGX
$6.14B
$18.1M 1.06%
172,125
CLDX icon
31
Celldex Therapeutics
CLDX
$2.34B
$15.9M 0.93%
500,000
+150,000
ZURA icon
32
Zura Bio
ZURA
$366M
$15.3M 0.89%
2,564,303
+750,632
NRIX icon
33
Nurix Therapeutics
NRIX
$1.6B
$15M 0.88%
967,620
SVRA icon
34
Savara
SVRA
$1.08B
$13.7M 0.8%
2,512,153
-285,000
CATX icon
35
Perspective Therapeutics
CATX
$406M
$13.2M 0.77%
3,164,582
+2,864,582
HLXC
36
Helix Acquisition Corp III
HLXC
$225M
$12.7M 0.74%
+1,250,000
ARWR icon
37
Arrowhead Research
ARWR
$10.2B
$12.5M 0.74%
200,000
+130,000
DMRA
38
Damora Therapeutics
DMRA
$1.37B
$11.7M 0.68%
+450,000
EPRX
39
Eupraxia Pharmaceuticals
EPRX
$414M
$11.5M 0.67%
1,589,005
+1,289,005
ANRO icon
40
Alto Neuroscience
ANRO
$662M
$11.2M 0.66%
+500,000
BBIO icon
41
BridgeBio Pharma
BBIO
$12.8B
$11.1M 0.65%
150,000
-170,000
CGEM icon
42
Cullinan Oncology
CGEM
$935M
$11.1M 0.65%
781,260
-1,150,846
BLTE
43
Belite Bio
BLTE
$5.5B
$10.4M 0.61%
65,000
+45,000
WVE icon
44
Wave Life Sciences
WVE
$1.11B
$10.2M 0.6%
1,401,727
-1,298,273
VERA icon
45
Vera Therapeutics
VERA
$2.24B
$10.1M 0.59%
250,000
TYRA icon
46
Tyra Biosciences
TYRA
$1.71B
$9.86M 0.58%
+257,512
RVMD icon
47
Revolution Medicines
RVMD
$33.2B
$9.72M 0.57%
100,000
JBIO
48
Jade Biosciences
JBIO
$868M
$8.99M 0.53%
639,956
-75,000
TVTX icon
49
Travere Therapeutics
TVTX
$4.2B
$8.91M 0.52%
300,000
NAMS icon
50
NewAmsterdam Pharma
NAMS
$3.75B
$8.8M 0.52%
275,000
1
2
3 4 5